Search Results for 'Vaccine'

Contract Service Directory Companies

View All Buyers Guide Companies »

Contract Service Directory Categories

View All Categories »

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
  

  WuXi AppTec Completes OXGENE Acquisition

  Expands Cell and Gene Therapy service offerings for global customers.

  Kristin Brooks 03.02.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
  

  Celonic Group Announces Plans for New Facility in Switzerland

  Will add up to 20 GMP clean room suites and offices along with laboratories.

  Charles Sternberg, Assistant Editor 03.01.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
  

  BMS Expands Cell Therapy Manufacturing Capabilities

  New state-of-the-art cell therapy manufacturing facility under construction to expand global footprint.

  Tim Wright, Editor, Contract Pharma 03.01.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  AMRI Contributes to Efforts to Increase COVID-19 Vax Supply

  Joins network of approved manufacturers of lipid excipients for Pfizer-BioNTech COVID-19 vaccine.

  Tim Wright, Editor, Contract Pharma 02.25.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Information Technology
  

  Pfizer Selects Seven Bridges to Support RNA Sequencing Data

  Seven Bridges will centralize and manage terabytes scRNASeq data, which provides detailed analysis of gene expression in individual cells.

  Kristin Brooks 02.24.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
  

  Catalent Acquires Delphi Genetics

  Launches US plasmid manufacturing site to establish global pDNA development and manufacturing capabilities.

  Tim Wright, Editor, Contract Pharma 02.23.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
  

  Avid Bioservices Begins Phase 2 of Myford Mfg. Expansion

  Build to include second manufacturing train with both upstream and downstream processing suites.

  Kristin Brooks 02.22.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
  

  MaxiVAX, Minaris Enter Cell Therapy Mfg. Agreement

  Minaris will provide GMP manufacturing, freezing and shipping of the MVX-ONCO-2 capsules from its site near Munich, Germany.

  Kristin Brooks 02.22.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
  

  G-CON Manufacturing Delivers & Installs PODs for Cell Therapy Manufacturing

  Successfully completes the project within the client’s required schedule.

  Charles Sternberg, Assistant Editor 02.19.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
  

  Intravacc Unveils New Pilot Vaccine Production Facility

  State-of-the-art pilot plant for production of vaccine candidates in clinical phase I & II research.

  Tim Wright, Editor, Contract Pharma 02.19.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
  

  Century Therapeutics Significantly Expands Capabilities

  Unveils new operational, laboratory and manufacturing facilities in Pennsylvania and New Jersey.

  Tim Wright, Editor, Contract Pharma 02.19.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  Pfizer, BioNTech To Supply 200M More Vax Doses to EU

  New agreement brings total supply to the European Union to 500 million doses, with delivery expected by the end of 2021.

  Charles Sternberg, Assistant Editor 02.17.21
  

  ---

• Vaccine Stability Considerations to Enable Rapid Development and Deployment

  ...

  02.17.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  Novavax, SK Bioscience Expand Vax Pact

  The existing partnership for manufacture of NVX-CoV2373 has been expanded to increase production capacity and supply vaccines to the Korean Government.

  Charles Sternberg, Assistant Editor 02.17.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
  

  Charles River Acquires CDMO Cognate BioServices

  Pays roughly $875 million to significantly expand capabilities in the cell and gene therapy sector.

  Tim Wright, Editor, Contract Pharma 02.17.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
  

  Kaneka Eurogentec Expands Capabilities

  Receives GMP accreditation for new mRNA manufacturing facility, COVID-19 vaccine production ongoing.

  Tim Wright, Editor, Contract Pharma 02.17.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
  

  Biomunex, Onward Ink Strategic Antibody Development Pact

  Exclusive worldwide license and development agreement will leverage Biomunex' next gen bi- and multi-specific antibody platform in hematological malignancies.

  Kristin Brooks 02.16.21
  

  ---

• APIs | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
  

  FUJIFILM Diosynth Hosts UK PM at COVID Vax Mfg. Site

  Billingham site to support the manufacture of up to 180 million doses Novavax’ NVX-CoV2373 COVID-19 vaccine candidate.

  Kristin Brooks 02.16.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  Pfizer, BioNTech to Supply the U.S. with 100mn Additional Doses of COVID-19 Vaccine

  U.S. government exercises option to bring total supply to 300 million doses, enabling vaccinations for 150 million people.

  Tim Wright, Editor, Contract Pharma 02.12.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Industry News
  

  Evonik Strengthens Partnership with BioNTech on COVID-19 Vaccine

  Establishment of additional lipid production in Germany for use with mRNA-based vaccines.

  Tim Wright, Editor, Contract Pharma 02.12.21
  

  ---

• Aseptic Processing | Biologics, Proteins, Vaccines | Injectables
  

  Seasonal Vaccine Manufacturing

  There are three areas to evaluate when selecting an outsourcing partner for seasonal vaccine manufacturing.

  ---

• Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development
  

  Molecular Templates, BMS Enter Strategic Research Pact

  Aims to discover and develop multiple therapies for specific oncology targets utilizing MTEM’s next-gen engineered toxin body (ETB) platform.

  Kristin Brooks 02.11.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
  

  Recipharm Bolsters Biologics Offering

  Extends manufacturing license to include immunology products at clinical and commercial scales, in both freeze-dried and liquid forms.

  Kristin Brooks 02.11.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
  

  Rentschler Biopharma Establishes Cell and Gene CoE

  Aims to address the gap in capacity and support for early-stage innovators in cell and gene therapy.

  Kristin Brooks 02.11.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
  

  AbbVie, Caribou Ink CAR-T Collaboration

  Leverages Caribou's next-generation CRISPR genome editing technology platform and AbbVie's antigen-specific binders.

  Tim Wright, Editor, Contract Pharma 02.10.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News
  

  RotaChrom Technologies Partners with Cyclolab

  Aims to develop a more efficient and cost-effective process to purify Remdesivir, a widely used treatment option for COVID-19.

  Charles Sternberg, Assistant Editor 02.09.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
  

  Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China

  Companies join forces in cell therapy applications and commercial-scale manufacturing.

  Tim Wright, Editor, Contract Pharma 02.08.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
  

  Vigene Plans Major Expansion in Maryland

  Global gene therapy and vaccine manufacturing company taking additional space in Rockville and adding up to 245 jobs.

  Tim Wright, Editor, Contract Pharma 02.08.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
  

  Paragon Biosciences Expands Cell and Gene Therapy Platform

  Launches CiRC Biosciences with an initial focus on developing eye disease treatments.

  Tim Wright, Editor, Contract Pharma 02.08.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
  

  Catalent, Trizell Enter Cell Therapy Deal

  Sign development and manufacturing agreement with for macrophage-based advanced cell therapy.

  Tim Wright, Editor, Contract Pharma 02.08.21
  

  ---

• Biologics, Proteins, Vaccines | Clinical Trials
  

  Inside a Vaccine Trial

  Dr. Murphy of ICON, provider of clinical services to Pfizer/BioNTech’s COVID vaccine program, discusses what it takes to conduct a vaccine trial of this scale.

  Online Exclusives Kristin Brooks, Managing Editor 02.05.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Industry News
  

  CureVac, UK Partner on Vaccines Against SARS-CoV-2 Variants

  Aims to mitigate the effects of the pandemic and help prepare against future SARS-CoV-2 outbreaks by working on multiple variant vaccines.

  Kristin Brooks 02.05.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
  

  J&J Submits EUA for Single-Shot Janssen COVID Vax Candidate

  Plans to distribute vaccine to U.S. government immediately following authorization, and expects to supply 100 million doses in 1H21.

  Kristin Brooks 02.05.21
  

  ---

• Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
  

  The Future of Vaccines and Biologics

  Dr. Linda Marbán of Capricor Therapeutics discusses the advances in responding to infectious diseases.

  Online Exclusives Kristin Brooks, Managing Editor, Contract Pharma 02.04.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
  

  Catalent, Decibel Team Up for Hearing Loss Treatment

  Enter development and manufacturing agreement for dual-vector gene therapy for the treatment of congenital hearing loss.

  Tim Wright, Editor, Contract Pharma 02.04.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Facilities | Industry News
  

  Wacker Strengthens Biologics Business

  Acquires US-based plasmid DNA manufacturer Genopis.

  Tim Wright, Editor, Contract Pharma 02.04.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
  

  Vaxart Oral COVID-19 Vax Tablet Shows Promise

  Phase I study reached primary and secondary endpoints of safety and immunogenicity.

  Kristin Brooks 02.03.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Drug Development | Industry News
  

  Immunome, Abzena Enter COVID-19 Antibody Cocktail Agreement

  Abzena will work with Immunome to produce the antibody cocktail for clinical testing.

  Kristin Brooks 02.03.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Process Validation | Scale-up/Technology Transfer
  

  Avid, Humanigen Enter Lenzilumab Mfg. Agreement

  To expand production capacity for lenzilumab, Humanigen’s therapeutic candidate in development to treat cytokine storm associated with COVID-19.

  Kristin Brooks 02.03.21
  

  ---

• Biologics, Proteins, Vaccines | cGMP Manufacture | Collaborations & Alliances
  

  GSK, CureVac Enter New €150M COVID Vax Pact

  GSK will support the manufacture of up to 100 million doses of CureVac’s first generation COVID-19 vaccine candidate CVnCoV in 2021.

  Kristin Brooks 02.03.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  Just, Evotec Expand mAbs Manufacturing Contract with DOD

  Will manufacture anti-SARS-CoV-2 and other antibodies at J.POD facility in Washington state.

  Tim Wright, Editor, Contract Pharma 02.02.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News
  

  UK Secures 40M Doses of Valneva COVID-19 Vax

  Brings the total volume of the Valneva vaccine ordered by UK Government to 100 million doses.

  Charles Sternberg, Assistant Editor 02.01.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
  

  CureVac, Rentschler Ramp up COVID Vax Production

  Rentschler responsible for manufacturing, downstream processing and formulation of CureVac’s CVnCoV in Laupheim, Germany.

  Kristin Brooks 02.01.21
  

  ---

• Biologics, Proteins, Vaccines | cGMP Manufacture | Facilities | Parenterals
  

  Making the Switch to Single-Use Technologies

  Why Avid Bioservices adopted single-use technologies over thirteen years ago and never looked back.

  Contract Pharma Staff

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News | Information Technology
  

  Cognate BioServices, Nucleus Biologics Form Cell & Gene Therapy Partnership

  Will focus on clinical and commercial clients, especially as Cognate expands its business with allogeneic and autologous on-demand cell and gene therapies.

  Tim Wright, Editor, Contract Pharma 01.29.21
  

  ---

• Aseptic Processing | Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News
  

  Novartis Inks Contract Manufacturing Deal for Pfizer-BioNTech COVID-19 Vaccine

  Novartis to leverage manufacturing capacity and capabilities to address pandemic, supporting global supply of COVID-19 vaccine.

  Tim Wright, Editor, Contract Pharma 01.29.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology
  

  Evozyne, Takeda Ink Strategic Protein Design Agreement

  Takeda will use Evozyne's evolution-based protein design technology to research and develop proteins for next-gen gene therapies.

  Kristin Brooks 01.28.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
  

  Lonza Launches Cryopreserved Leukopaks

  Customizable cryopreserved Leukopaks aim to provide greater flexibility in immunology and cell therapy research.

  Kristin Brooks 01.28.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
  

  Valneva Begins COVID Vax Production to Optimize Potential Deliveries

  Inactivated, adjuvanted COVID-19 vaccine candidate is in Phase 1/2 clinical development with initial results in April 2021.

  Kristin Brooks 01.28.21
  

  ---

• Biologics, Proteins, Vaccines
  

  Vaccines 2021

  Looking at the behavioral economics of vaccinations.

  Ben Locwin, Contributing Editor 01.27.21
  

  ---